Lilly Launches 'Innovation Challenge'
Eli Lilly and Co. (NYSE: LLY) has launched what it calls an open innovation challenge asking researchers nationwide to submit innovative digital health solutions to inform inflammatory bowel disease care. Lilly says the finalist who submits the winning idea will win $50,000.
The challenge focuses on advancements in IBD monitoring, condition management or care enhancements.
Mobile apps, sensors and wearables, algorithms and digital games will all be considered as part of the challenge.
The finalist with the winning idea, subject to the submissions received, will be announced in Q4 2019, and will be awarded $50,000 along with the potential opportunity to co-develop the solution with Lilly.
"Lilly is investing in digital solutions that can help empower people with chronic conditions, such as IBD, to better manage their own health. Innovation is happening everywhere, and this challenge is aimed at identifying bold ideas outside our walls and collaborating on ways to potentially deliver new solutions to those who need them most," said Divakar Ramakrishnan, Ph.D., chief digital officer at Lilly in a news release.
"Approximately 3 million Americans have reported being diagnosed with IBD, and Lilly is committed to tackling the challenge of this disease through science and innovation. We're looking for digital innovators to join us."
Submissions will be accepted through September 30. The judges will review submissions through October and aim to select five finalists by early November.
To connect to the submission form, including criteria, eligibility and requirements, click here.